Publications
5600 Results
- Journal / Conference
- Journal of Thoracic Oncology, Feb; 10(2):387-391
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25611229
- PMC
- PMC4304604
- Study Number(s)
- S0722
Phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM): SWOG S0722
- Journal / Conference
- Journal of Clinical Oncology, Apr 1;33(10):1157-1164
- Year
- 2015
- Research Committee(s)
- Leukemia
- PMID
- PMID25713434
- PMC
- PMC437285
- Study Number(s)
- S0106, SWOG-9031, SWOG-9333, SWOG-9500
Prognostic significance of NPM1 mutations in the absence of FLT3-Internal Tandem Duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report
- Journal / Conference
- Journal of the National Cancer Institute Dec 24;107(2)
- Year
- 2015
- Research Committee(s)
- Cancer Care Delivery and Outcomes and Comparative Effectiveness
- PMID
- PMID25540245
- PMC
- PMC4326312
The diffusion of docetaxel in patients presenting with metastatic prostate cancer
- Journal / Conference
- PLOS ONE 2015 Apr 17;10(4):e0118485. doi: 10.1371/journal.pone.0118485
- Year
- 2015
- Research Committee(s)
- Leukemia
- PMID
- PMID25884949
- PMC
- PMCID4401549
- Study Number(s)
- S0112, S0301, SWOG-9031, SWOG-9333
Cell signalling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia
- Journal / Conference
- International Journal of Cancer Apr 15;136(8):1856-1862
- Year
- 2015
- Research Committee(s)
- Genitourinary
- PMID
- PMID25219358
- PMC
- PMC4323674
- Study Number(s)
- S0421
Circulating tumor cell telomerase activity as a prognostic marker for overall survival in metastatic castration resistant prostate cancer: results from SWOG S0421
- Journal / Conference
- Urology Mar;85(3):616-620
- Year
- 2015
- Research Committee(s)
- Cancer Control
- PMID
- PMID25733274
- PMC
- PMC4348556
- Study Number(s)
- SWOG-9217
Effect of finasteride on serum androstenedione and risk of prostate cancer within the Prostate Cancer Prevention Trial: differential effect on high and low grade disease
- Journal / Conference
- JAMA Opthalmology 133(1):17-24
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25232809
- PMC
- PMC4395006
- Study Number(s)
- S0000B
Age-related Cataract in a Randomized Trial of Selenium and Vitamin E in Men: The SELECT Eye Endpoints (SEE) Study
- Journal / Conference
- Leukemia 29(2):312-320
- Year
- 2015
- Research Committee(s)
- Leukemia
- PMID
- PMID25113226
- PMC
- PMC4318722
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9333, SWOG-9500, S9617, S9918
Resistance prediction in AML: analysis of 4,601 patients from MRC/NCRI, HOVON/SAKK, SWOG, and MD Anderson Cancer Center
- Journal / Conference
- International Journal of Cancer 136(5):1210-1217
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25044450
- PMC
- PMC4268262
- Study Number(s)
- S0000
Generalizability of established prostate cancer risk variants in men of African-ancestry
- Journal / Conference
- Biology of Blood and Marrow Transplantation Mar;21(3):559-564
- Year
- 2015
- Research Committee(s)
- Leukemia
- PMID
- PMID25536215
- PMC
- PMC4386840
- Study Number(s)
- S0106